tiprankstipranks
Q32 Bio (QTTB)
NASDAQ:QTTB
US Market

Q32 Bio (QTTB) Income Statement

913 Followers

Q32 Bio Income Statement

Last quarter (Q4 2025), Q32 Bio's total revenue was $53.74M, an increase of Infinity% from the same quarter last year. In Q4, Q32 Bio's net income was $57.73M. See Q32 Bio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 53.74M$ 0.00$ -6.65M$ 6.65M$ 33.97M
Gross Profit
$ 53.35M$ -487.00K$ -6.65M$ 6.65M$ 24.43M
Operating Expenses
$ 36.44M$ 65.61M$ 41.60M$ 45.88M$ 120.38M
Depreciation and Amortization
$ 391.00K$ 487.00K$ 499.00K$ 370.00K$ 9.54M
EBITDA
$ 17.29M$ -45.30M$ -47.76M$ -38.85M$ -86.22M
Operating Income
$ 16.90M$ -66.10M$ -48.26M$ -39.23M$ -95.95M
Other Income/Expenses
$ 12.92M$ 18.39M$ -5.17M$ -3.52M$ 185.00K
Pretax Income
$ 29.82M$ -47.71M$ -53.42M$ -42.75M$ -95.76M
Net Income
$ 29.82M$ -47.73M$ -53.74M$ -42.81M$ -95.76M
Per Share Metrics
Basic EPS
$ 2.42$ -5.12$ -16.70$ -13.42$ -31.18
Diluted EPS
$ 2.42$ -6.58$ -16.70$ -13.42$ -31.18
Weighted Average Shares Outstanding
12.30M 12.20M 3.22M 3.19M 3.07M
Weighted Average Shares Outstanding (Diluted)
12.31M 12.20M 3.22M 3.19M 3.07M
Currency in USD

Q32 Bio Earnings and Revenue History